Integrated Wealth Concepts LLC Sells 5,868 Shares of The Procter & Gamble Company (NYSE:PG)

Integrated Wealth Concepts LLC cut its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 3.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 146,288 shares of the company’s stock after selling 5,868 shares during the period. Integrated Wealth Concepts LLC’s holdings in Procter & Gamble were worth $25,337,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of PG. Itau Unibanco Holding S.A. bought a new position in shares of Procter & Gamble in the 2nd quarter worth $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble during the second quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble in the third quarter valued at approximately $33,000. POM Investment Strategies LLC purchased a new position in Procter & Gamble in the second quarter worth approximately $34,000. Finally, Quest Partners LLC purchased a new position in shares of Procter & Gamble during the second quarter worth $36,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $178.44 on Tuesday. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $180.43. The firm has a market cap of $420.23 billion, a PE ratio of 30.98, a price-to-earnings-growth ratio of 3.86 and a beta of 0.44. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The company’s 50 day moving average is $170.48 and its two-hundred day moving average is $169.11.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s revenue was down .6% on a year-over-year basis. During the same period in the prior year, the business earned $1.83 earnings per share. On average, research analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.26%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. This represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 83,080 shares of company stock valued at $14,629,038 in the last three months. 0.18% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on PG shares. Morgan Stanley boosted their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. JPMorgan Chase & Co. increased their target price on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Evercore ISI raised their target price on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Piper Sandler began coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price on the stock. Finally, DA Davidson raised Procter & Gamble from a “neutral” rating to a “buy” rating and lifted their price target for the company from $160.00 to $209.00 in a report on Monday, November 25th. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $180.45.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.